|
1
|
Arber N and Levin B: Chemoprevention of
colorectal cancer; ready for routine use? Recent results. Cancer
Res. 166:213–230. 2005.PubMed/NCBI
|
|
2
|
Siegel R, Naishadham D and Jamal A: Cancer
statistics. CA Cancer J Clin. 62:10–29. 2012.
|
|
3
|
Mehta RG, Munillo G, Naithani R and
Xinjian P: Cancer chemoprevention by natural products: how far have
we come. Pharm Res. 27:950–961. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Frankfurt OS and Krishnan A:
Apoptosis-based drug screening and detection of selective toxicity
to cancer cells. Anticancer Drugs. 14:555–561. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wang YC and Huang TL: Screening of
anti-Helicobacter pylori herbs deriving from Taiwanese folk
medicinal plants. FEMS Immunol Med Microbiol. 43:51–59. 2005.
|
|
6
|
Wang YC and Huang TL: Anti-Helicobacter
pylori activity of Plumbago zeylanica L. FEMS Immunol
Med Microbiol. 43:407–412. 2005.
|
|
7
|
Dai Y, Hou L, Cheng YP and But PP:
Inhibition of immediate allergic reactions by ethanol extract from
Plumbago zeylanica stems. Biol Pharm Bull. 27:429–432. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chan-Bacab MJ and Pena-Rodriguez LM: Plant
natural products with leishmanicidal activity. Nat Prod Rep.
18:674–688. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Krishnaswamy M and Purushothaman KK:
Plumbagin: a study of its anticancer, antibacterial and antifungal
properties. Indian J Exp Biol. 18:876–877. 1980.PubMed/NCBI
|
|
10
|
Sharma I, Gusain D and Dixit VP:
Hypolipidaemic and anti-atherosclerotic effects of plumbagin in
rabbits. Indian J Physiol Pharmacol. 35:59–63. 1991.
|
|
11
|
Parimala R and Sachdanandem P: Effect of
plumbagin on some glucose metabolizing enzymes studied in rats in
experimental hepatoma. Mol Cell Biochem. 125:10–14. 1996.
|
|
12
|
Naresh RA, Udupa N and Devi PU: Niosomal
plumbagin with reduced toxicity and improved anticancer activity in
BALB/C mice. J Pharmacol. 48:1128–1132. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sugie S, Okamoto K, Rahman KM, et al:
Inhibitory effects of plumbagin and juglone on azoxymethane-induced
intestinal carcinogenesis in rats. Cancer Lett. 127:177–183.
1998.PubMed/NCBI
|
|
14
|
Srinivas P, Gopinath G, Banerji A, Dinakar
A and Srinivas G: Plumbagin induces reactive oxygen species, which
mediate apoptosis in human cervical cancer cells. Mol Carcinog.
40:201–211. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kuo PL, Hsu YL and Cho CY: Plumbagin
induces G2-M arrest and autophagy by inhibiting the AKT/mammalian
target of rapamycin pathway in breast cancer cells. Mol Cancer
Ther. 5:3209–3221. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hsu YL, Cho CY, Kuo PL, Huang YT and Lin
CC: Plumbagin induces apoptosis and cell cycle arrest in A549 cells
through p53 accumulation via c-Jun NH2- terminal kinase-mediated
phosphorylation at serine 15 in vitro and in vivo. J Pharmacol Exp
Ther. 318:484–494. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Devi PU, Rao BS and Solomon FE: Effect of
plumbagin on the radiation induced cytogenetic and cell cycle
changes in mouse Ehrlich ascites carcinoma in vivo. Indian J Exp
Biol. 36:891–895. 1998.PubMed/NCBI
|
|
18
|
Prasad VS, Devi PU, Rao BS and Kamath R:
Radiosensitizing effect of Plumbagin on mouse melanoma cells grown
in vitro. Indian J Biol. 34:857–858. 1996.PubMed/NCBI
|
|
19
|
Ganasoundari A, Zare SM and Devi PU:
Modification of bone marrow radiosensitivity by medicinal plant
extracts. Br J Radiol. 70:599–602. 1996. View Article : Google Scholar
|
|
20
|
Subramaniya BR, Srinivas G, Sadullah SSM,
et al: Apoptosis inducing effect of Plumbagin on colonic cancer
cells depends on expression of COX-2. PLoS One. 6:1–11. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Seyfried TN and Huysentruyt LC: On the
origin of cancer metastasis. Crit Rev Oncog. 18:43–73. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Nguyen DX, Bos PD and Massagué J:
Metastasis: from dissemination to organ-specific colonization. Nat
Rev Cancer. 9:274–284. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
23
|
Liotta LA and Kohn E: Anoikis: cancer and
the homeless cell. Nature. 430:973–974. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Konstantopoulos K and Thomas SN: Cancer
cells in transit: the vascular interactions of tumor cells. Annu
Rev Biomed Eng. 11:177–202. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Jiang YL and Liu ZP: Natural products as
anti-invasive and anti-metastatic agents. Curr Med Chem.
18:808–829. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Simon HU, Haj-Yehia A and Levi-Schaffer F:
Role of reactive oxygen species (ROS) in apoptosis induction.
Apoptosis. 5:415–418. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Circu ML and Aw TY: Reactive oxygen
species, cellular redox systems and apoptosis. Free Radic Biol Med.
48:749–762. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Gupta SC, Kim JH, Prasad S and Aggarwal
BB: Regulation of survival, proliferation, invasion, angiogenesis,
and metastasis of tumor cells through modulation of inflammatory
pathways by nutraceuticals. Cancer Metastasis Rev. 29:405–434.
2010. View Article : Google Scholar
|
|
29
|
Kaufmann SH and Earnshaw WC: Induction of
apoptosis by cancer chemotherapy. Exp Cell Res. 256:42–49. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lu JJ, Bao JL, Wu GS, et al: Quinones
derived from plant secondary metabolites as anti-cancer agents.
Anticancer Agents Med Chem. 13:456–463. 2013.PubMed/NCBI
|
|
31
|
Padhye S, Dandawate P, Yusufi M, Ahmad A
and Sarkar FH: Perspectives on medicinal properties of Plumbagin
and its analogs. Med Res Rev. 32:1131–1158. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Li J, Shen L, Lu FR, et al: Plumbagin
inhibits cell growth and potentiates apoptosis in human gastric
cancer cells in vitro through the NF-κB signaling pathway. Acta
Pharmacol Sin. 33:242–249. 2012.PubMed/NCBI
|
|
33
|
Hafeez BB, Jamal MS, Fischer JW, Mustafa A
and Verma AK: Plumbagin, a plant derived natural agent inhibits the
growth of pancreatic cancer cells in vitro and in vivo via
targeting EGFR, Stat3 and NF-κB signaling pathways. Int J Cancer.
131:2175–2186. 2012.PubMed/NCBI
|
|
34
|
Sinha S, Pal K, Elkhanany A, et al:
Plumbagin inhibits tumorigenesis and angiogenesis of ovarian cancer
cells in vivo. Int J Cancer. 132:1201–1212. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Abedinpour P, Baron VT, Chrastina A, Welsh
J and Borgström P: The combination of Plumbagin with androgen
withdrawal causes profound regression of prostate tumors in vivo.
Prostate. 73:489–499. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Xu TP, Shen H, Liu LX and Shu YQ:
Plumbagin from Plumbago zeylanica L induces apoptosis in
human non-small cell lung cancer cell lines through NF-κB
inactivation. Asian Pac J Cancer Prev. 14:2325–2331. 2013.
|
|
37
|
Sagar S, Esau L, Moosa B, Khashab NM,
Bajic VB and Kaur M: Cytotoxicity and apoptosis induced by a
Plumbagin derivative in estrogen positive MCF-7 breast cancer
cells. Anticancer Agents Med Chem. 14:170–180. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Subramaniya BR, Srinivasan G, Sadullah SS,
et al: Apoptosis inducing effect of plumbagin on colonic cancer
cells depends on expression of COX-2. PLoS One. 6:e186952011.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Chen MB, Zhang Y, Wei MX, et al:
Activation of AMP-activated protein kinase (AMPK) mediates
plumbagin-induced apoptosis and growth inhibition in cultured human
colon cancer cells. Cell Signal. 25:1993–2002. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Wu Y, Mehew JW, Heckman CA, Arcinas M and
Boxer LM: Negative regulation of bcl-2 expression by p53 in
hematopoietic cells. Oncogene. 20:240–251. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Mérino D, Giam M, Hughes PD, et al: The
role of BH3-only protein Bim extends beyond inhibiting Bcl-2-like
prosurvival proteins. J Cell Biol. 186:355–362. 2009.PubMed/NCBI
|
|
42
|
Sandur SK, Ichikawa H, Sethi G, Ahn KS and
Aggarwal BB: Plumbagin (5-hydroxy-2-methyl-1,4-naphthoquinone)
suppresses NF-κB activation and NF-κB-regulated gene products
through modulation of p65 and IκBα kinase activation, leading to
potentiation of apoptosis induced by cytokine and chemotherapeutic
agents. J Biol Chem. 281:17023–17033. 2006.PubMed/NCBI
|
|
43
|
Nambiar D, Rajamani P and Singh RP:
Effects of phytochemicals on ionization radiation-mediated
carcinogenesis and cancer therapy. Mutat Res. 728:139–157. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Powolny AA and Singh SV: Plumbagin-induced
apoptosis in human prostate cancer cells is associated with
modulation of cellular redox status and generation of reactive
oxygen species. Pharm Res. 25:2171–2180. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Checker R, Sharma D, Santosh SK, et al:
Plumbagin inhibits proliferative and inflammatory response of T
cells independent of ROS generation but by modulating intracellular
thiols. J Cell Biochem. 110:1082–1093. 2011. View Article : Google Scholar
|
